GlaxoSmithKline S.A.E reported standalone and consolidated financial results for the quarter ended March 31, 2021. For the quarter, on standalone basis, the company reported net profit of EGP 22,212,767 against EGP 31,911,062 for the same period of last year. For the quarter, on standalone basis, the company reported net profit of EGP 2,699,251 against EGP 33,147,580 for the same period of last year.